These experiments independently confirm that the secretion of Apo A1 into plasma is increasingly inhibited during LC and HCC development; α1AT levels are marginally increased with LC followed by a marked up-regulation with progression to HCC. This evidence concerns the gene SERPINA1 and hepatocellular carcinoma.